(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.43%) $78.82
(0.41%) $2.20
(0.15%) $2 334.60
(0.29%) $27.70
(0.23%) $967.10
(-0.05%) $0.928
(-0.44%) $10.83
(-0.13%) $0.796
(-0.12%) $91.34
1.90% $ 2.15
Live Chart Being Loaded With Signals
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 5 848.00 |
Średni wolumen | 26 046.00 |
Kapitalizacja rynkowa | 18.20M |
EPS | $0 ( 2024-03-15 ) |
Następna data zysków | ( $0 ) 2024-07-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.450 |
ATR14 | $0.0340 (1.58%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-20 | Weinstein Robert | Buy | 61 248 | Stock Option (Right to Buy) |
2023-11-20 | Walker Wayne Remell | Buy | 61 248 | Stock Option (Right to Buy) |
2023-11-20 | Trujillo Carlos | Buy | 85 000 | Stock Option (Right to Buy) |
2023-11-20 | Silverman Joshua | Buy | 170 000 | Stock Option (Right to Buy) |
2023-11-20 | Schechter Jonathan | Buy | 61 248 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
57.61 |
Last 54 transactions |
Buy: 749 992 | Sell: 831 346 |
PharmaCyte Biotech, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PharmaCyte Biotech, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.220 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.220 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.260 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.45 |
Financial Reports:
No articles found.
PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej